Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Irwin

Showing results (31-40 of 100) with videos related to

Pageof 10
Sort By:
European Radiology|February 24, 2024
Magnetic resonance imaging-guided renal biopsy shows high safety and diagnostic yield: a tertiary cancer center experienceMohamed E Abdelsalam, Thomas Lu, Ali Baiomy, et al.
Plos One|June 25, 2014
Anti-hypotensive treatment and endothelin blockade synergistically antagonize exercise fatigue in rats under simulated high altitudeDaniel Radiloff, Yulin Zhao, Alina Boico, et al.
Cancers|May 25, 2024
Magnetic-Resonance-Imaging-Guided Cryoablation for Solitary-Biopsy-Proven Renal Cell Carcinoma: A Tertiary Cancer Center ExperienceMohamed E Abdelsalam, Nabeel Mecci, Ahmed Awad, et al.
Cancers|February 11, 2023
Outcomes of Radiofrequency Ablation for Solitary T1a Renal Cell Carcinoma: A 20-Year Tertiary Cancer Center ExperienceMohamed E Abdelsalam, Ahmed Awad, Ali Baiomy, et al.
Blood|July 16, 2005
Clinical factors predictive of outcome with bortezomib in patients with relapsed, refractory multiple myelomaPaul Gerard Guy Richardson, Bart Barlogie, James Berenson, et al.
Biomedicines|June 26, 2025
Technique and Outcomes of Radiofrequency Ablation of Biopsy-Proven 3-4 cm T1a Renal Cell CarcinomaMohamed E Abdelsalam, Ahmed Awad, Roland L Bassett, et al.
British Journal of Haematology|September 4, 2009
Impact of prior therapies on the relative efficacy of bortezomib compared with dexamethasone in patients with relapsed/refractory multiple myelomaDan T Vogl, Edward A Stadtmauer, Paul G Richardson, et al.
Blood Advances|December 18, 2024
Nbeal2 knockout mice are not protected against hypoxia-induced pulmonary vascular remodeling and pulmonary hypertensionJanelle N Posey, Mariah Jordan, Caitlin V Lewis, et al.
British Journal of Haematology|November 7, 2008
Bortezomib is associated with better health-related quality of life than high-dose dexamethasone in patients with relapsed multiple myeloma: results from the APEX studyStephanie J Lee, Paul G Richardson, Pieter Sonneveld, et al.
Brain Communications|October 23, 2023
Anterior cingulate sulcation is associated with onset and survival in frontotemporal dementiaLuke Harper, Sterre de Boer, Olof Lindberg, et al.
Pageof 10

Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
European Radiology|February 24, 2024
Magnetic resonance imaging-guided renal biopsy shows high safety and diagnostic yield: a tertiary cancer center experienceMohamed E Abdelsalam, Thomas Lu, Ali Baiomy, et al.
Plos One|June 25, 2014
Anti-hypotensive treatment and endothelin blockade synergistically antagonize exercise fatigue in rats under simulated high altitudeDaniel Radiloff, Yulin Zhao, Alina Boico, et al.
Cancers|May 25, 2024
Magnetic-Resonance-Imaging-Guided Cryoablation for Solitary-Biopsy-Proven Renal Cell Carcinoma: A Tertiary Cancer Center ExperienceMohamed E Abdelsalam, Nabeel Mecci, Ahmed Awad, et al.
Cancers|February 11, 2023
Outcomes of Radiofrequency Ablation for Solitary T1a Renal Cell Carcinoma: A 20-Year Tertiary Cancer Center ExperienceMohamed E Abdelsalam, Ahmed Awad, Ali Baiomy, et al.
Blood|July 16, 2005
Clinical factors predictive of outcome with bortezomib in patients with relapsed, refractory multiple myelomaPaul Gerard Guy Richardson, Bart Barlogie, James Berenson, et al.
Biomedicines|June 26, 2025
Technique and Outcomes of Radiofrequency Ablation of Biopsy-Proven 3-4 cm T1a Renal Cell CarcinomaMohamed E Abdelsalam, Ahmed Awad, Roland L Bassett, et al.
British Journal of Haematology|September 4, 2009
Impact of prior therapies on the relative efficacy of bortezomib compared with dexamethasone in patients with relapsed/refractory multiple myelomaDan T Vogl, Edward A Stadtmauer, Paul G Richardson, et al.
Blood Advances|December 18, 2024
Nbeal2 knockout mice are not protected against hypoxia-induced pulmonary vascular remodeling and pulmonary hypertensionJanelle N Posey, Mariah Jordan, Caitlin V Lewis, et al.
British Journal of Haematology|November 7, 2008
Bortezomib is associated with better health-related quality of life than high-dose dexamethasone in patients with relapsed multiple myeloma: results from the APEX studyStephanie J Lee, Paul G Richardson, Pieter Sonneveld, et al.
Brain Communications|October 23, 2023
Anterior cingulate sulcation is associated with onset and survival in frontotemporal dementiaLuke Harper, Sterre de Boer, Olof Lindberg, et al.
Pageof 10